The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Impact of Pretransplant Anti-HLA Antibodies on Outcomes in Lung Transplant Candidates
Abstract
Rationale: The prevalence of anti-HLA antibodies in lung transplant candidates and their impact on waitlist and transplant outcomes is not known. Objectives: We examined the prevalence of pretransplant anti-HLA antibodies at varying thresholds and evaluated their impact on outcomes before and after lung transplantation. Methods: We performed a single-center retrospective cohort study including all patients listed for lung transplantation between January 2008 and August 2012. Per protocol, transplant candidates were assessed by solid phase LABscreen mixed Class I and II and LABscreen Single Antigen assays. Measurements and Main Results: Among 224 patients, 34% had anti-HLA antibodies at mean fluorescent intensity (MFI) greater than or equal to 3,000 (group III), and 24% had antibodies at MFI 1,000 to 3,000 (group II). Ninety percent of the patients with pretransplant anti-HLA antibodies had class I antibodies, whereas only seven patients developed class II alone. Patients in group III were less likely to receive transplants than patients without any anti-HLA antibodies (group I) (45.5 vs. 67.7%, P = 0.005). Wait time to transplant was longer in group III than group I, although this difference did not meet statistical significance, and waitlist mortality was similar. Among transplant recipients, antibody-mediated rejection (AMR) was more frequent in group III than in group II (20% vs. 0%, P = 0.01) or group I (6.3%, P = 0.05). Conclusions: The presence of anti-HLA antibodies at the high MFI threshold (>3,000) was associated with lower transplant rate and higher rates of AMR. Screening for anti-HLA antibodies using the 3,000 MFI threshold may be important in managing transplant candidates and recipients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated HLA specific antibodies detected in peripheral blood may make finding a compatible donor difficult and may predict poor outcomes.(59–61)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [60]
In the citing paper
“Elevated HLA specific antibodies detected in peripheral blood may make finding a compatible donor difficult and may predict poor outcomes.(59–61)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [60]
Citations
Cites
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
Lefaucheur, C., Loupy, A., Hill, G. S., Andrade, J., Nochy, D., Antoine, C., Gautreau, C., Charron, D., Glotz, D., & Suberbielle-Boissel, C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009101065 · Cited by 789
Rejection of the Kidney Allograft
Nankivell, B. J., & Alexander, S. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0902927 · Cited by 605
Antibody-mediated organ-allograft rejection
Colvin, R. B., & Smith, R. N. (2005) · Nature Reviews Immunology · doi:10.1038/nri1702 · Cited by 492
Crespo, M., Pascual, M., Tolkoff-Rubin, N., Mauiyyedi, S., Bernard Collins, A., Fitzpatrick, D., Lin Farrell, M., Williams, W. W., Delmonico, F. L., Benedict Cosimi, A., et al. (2001) · Transplantation · doi:10.1097/00007890-200103150-00013 · Cited by 351
Amico, P., Hönger, G., Mayr, M., Steiger, J., Hopfer, H., & Schaub, S. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a5e034 · Cited by 258
Hachem, R. R., Yusen, R. D., Meyers, B. F., Aloush, A. A., Mohanakumar, T., Patterson, G. A., & Trulock, E. P. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.05.006 · Cited by 235
Palmer, S. M., Davis, R. D., Hadjiliadis, D., Hertz, M. I., Howell, D. N., Ward, F. E., Savik, K., & Reinsmoen, N. L. (2002) · Transplantation · doi:10.1097/00007890-200209270-00011 · Cited by 195
Sundaresan, S., Mohanakumar, T., Smith, M. A., Trulock, E. P., Lynch, J., Phelan, D., Cooper, J. D., & Patterson, G. A. (1998) · Transplantation · doi:10.1097/00007890-199803150-00008 · Cited by 192
Girnita, A. L., Duquesnoy, R., Yousem, S. A., Iacono, A. T., Corcoran, T. E., Buzoianu, M., Johnson, B., Spichty, K. J., Dauber, J. H., Burckart, G., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00650.x · Cited by 165
Lobo, L. J., Aris, R. M., Schmitz, J. L., & Neuringer, I. P. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.10.007 · Cited by 162
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Levine, D. J., Glanville, A. R., Aboyoun, C., Belperio, J., Benden, C., Berry, G. J., Hachem, R., Hayes, D., Neil, D., Reinsmoen, N. L., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.01.1223 · Cited by 488
Tikkanen, J. M., Singer, L. G., Kim, S. J., Li, Y., Binnie, M., Chaparro, C., Chow, C.-W., Martinu, T., Azad, S., Keshavjee, S., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1857oc · Cited by 186
Survival in Sensitized Lung Transplant Recipients With Perioperative Desensitization
Tinckam, K. J., Keshavjee, S., Chaparro, C., Barth, D., Azad, S., Binnie, M., Chow, C. W., de Perrot, M., Pierre, A. F., Waddell, T. K., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13076 · Cited by 161
The genesis and evolution of bead-based multiplexing
Graham, H., Chandler, D. J., & Dunbar, S. A. (2019) · Methods · doi:10.1016/j.ymeth.2019.01.007 · Cited by 116
Metadata
- Authors
- Kim, M., Townsend, K. R., Wood, I. G., Boukedes, S., Guleria, I., Gabardi, S., El-Chemaly, S., Camp, P. C., Chandraker, A. K., Milford, E. L., & Goldberg, H. J.
- Affiliations
- Heart Transplant Program, Center for Advanced Heart Disease, Department of Medicine
- Department of Pharmacy Services
- Tissue Typing Lab
- Lung Transplant Program, Division of Pulmonary and Critical Care Medicine, Department of Medicine
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Goldberg, Hilary J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-05
- Volume
- 189
- Issue
- 10
- Pages
- 1234-1239
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2094516159
- Semantic Scholar
- b581e6dcba3d7268c5bf5b78a2d77240479cce7b
- Cited by
- 72
- References
- 22
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 8 · 2020: 4 · 2019: 6 · 2018: 12 · 2017: 7 · 2016: 7 · 2015: 10
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- HLA antibodies, lung transplantation, transplant candidates, antibody-mediated rejection, HLA class I antibodies, HLA class II antibodies, transplant waiting list, transplant rates, waitlist mortality
- MeSH terms
- Adult, Aged, Female, Graft Rejection, Graft Survival, Histocompatibility Testing, HLA Antigens, Humans, Immunologic Factors, Isoantibodies, Male, Middle Aged, Preoperative Care, Retrospective Studies, Tissue Donors, Cohort Studies, Biomarkers, Lung Transplantation, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Pretransplant Anti-HLA Antibodies on Outcomes in Lung Transplant Candidates. https://app.cochat.ai/papers/10.1164/rccm.201312-2160oc
- The paper
- Kim, M., Townsend, K. R., Wood, I. G., Boukedes, S., Guleria, I., Gabardi, S., El-Chemaly, S., Camp, P. C., Chandraker, A. K., Milford, E. L., & Goldberg, H. J. (2014). Impact of Pretransplant Anti-HLA Antibodies on Outcomes in Lung Transplant Candidates. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201312-2160oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.